Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ironwood/Forest Hoping To Change The Conversation About Constipation

This article was originally published in The Pink Sheet Daily

Executive Summary

The partners began a DTC campaign to promote their constipation drug and ease the conversation between physicians and patients about the often embarrassing condition.

Advertisement

Related Content

Ironwood Could Use Linzess As Model For GERD Market
Actavis Flexes Its Commercial Muscles Ahead Of Allergan Integration
Synthetic Biologics Thinks Statins May Get At Root Of IBS-Constipation
Forest Keeps Wheeling And Dealing Ahead Of Merger
Ironwood’s Next Steps For Linzess: DTC and Traditional Lifecycle Management
Linzess Continues On Strong Launch Trajectory, Says Ironwood/Forest
Schooled On Prilosec And Zelnorm: Ironwood/Forest Aim Linzess At OTC-Dominated Market
Market Snapshot: Taking Constipation Seriously – Linaclotide Success Raises Hopes For Market Resurgence

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS077095

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel